Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00661_DB01143_nanopub.RAp7Z4ohsHxKYcu_KfzUMDG4C8BWKcGlfk_u7q7_yz-uI#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00661_DB01143 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00661_DB01143 label "DDI between Verapamil and Amifostine - Verapamil may enhance the hypotensive effect of Amifostine. At chemotherapeutic doses of Amifostine, Verapamil should be withheld for 24 hours prior to Amifostine administration. Caution should be used at lower Amifostine doses used during radiotherapy, but routine interruption of Verapamil therapy is not recommended. [drugbank_resource:DB00661_DB01143]" assertion.
- drugbank_resource:DB00661_DB01143 identifier "drugbank_resource:DB00661_DB01143" assertion.
- drugbank_resource:DB00661_DB01143 title "DDI between Verapamil and Amifostine - Verapamil may enhance the hypotensive effect of Amifostine. At chemotherapeutic doses of Amifostine, Verapamil should be withheld for 24 hours prior to Amifostine administration. Caution should be used at lower Amifostine doses used during radiotherapy, but routine interruption of Verapamil therapy is not recommended." assertion.
- drugbank:DB00661 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00661_DB01143 assertion.
- drugbank:DB01143 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00661_DB01143 assertion.